The Added Value of Double Dose Gadolinium Enhanced 3D T2 Fluid-Attenuated Inversion Recovery for Evaluating Small Brain Metastases
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: Single dose gadolinium (Gd) enhanced fluid-attenuated inversion recovery(FLAIR) is helpful for visualizing superficial parenchymal metastases. However,the usefulness of FLAIR with a higher dose of Gd is uncertain. The aim of our study was two-folds: first, to prove that the signal to noise ratio (SNR) of small brain metastases is higher than large brain metastases on double-dose (DD) enhancedFLAIR and, second, to explore the added value of DD Gd enhanced FLAIR in relation to T1 GRE for evaluating small brain metastases. Materials and Methods:For the first purpose, 50 pairs of small (2 mm<diameter≤5 mm) and large brain metastases (diameter >5 mm) were included. The difference in the SNR and contrast ratio (CR) between small and large metastases on DD Gd-enhanced 3D T2 FLAIR was compared by Wilcoxon signed-rank tests. For the second purpose, a totalof 404 small metastases were included. The diagnostic sensitivities between 3D T1 gradient echo (GRE) alone and combined results of 3D T1 GRE and 3D T2 FLAIR were compared with McNemar test. Results: The SNR and CR of small brain metastases were significantly higher than those of large brain metastases (p<0.001). In qualitative analysis, the diagnostic sensitivities for small brain metastaseswere significantly higher for 3D T1 GRE plus 3D T2 FLAIR than 3D T1 GRE alone regardless of scan time (p<0.001). Conclusion: Small brain metastases showed higher signal intensity than large brain metastases on the DD Gd enhanced 3D T2 FLAIR images. DD Gd enhanced 3D T2 FLAIR imaging may have a complementaryrole to 3D T1 GRE for evaluating small brain metastases.
Abstract
Purpose: Single dose gadolinium (Gd) enhanced fluid-attenuated inversion recovery(FLAIR) is helpful for visualizing superficial parenchymal metastases. However,the usefulness of FLAIR with a higher dose of Gd is uncertain. The aim of our study was two-folds: first, to prove that the signal to noise ratio (SNR) of small brain metastases is higher than large brain metastases on double-dose (DD) enhancedFLAIR and, second, to explore the added value of DD Gd enhanced FLAIR in relation to T1 GRE for evaluating small brain metastases. Materials and Methods:For the first purpose, 50 pairs of small (2 mm<diameter≤5 mm) and large brain metastases (diameter >5 mm) were included. The difference in the SNR and contrast ratio (CR) between small and large metastases on DD Gd-enhanced 3D T2 FLAIR was compared by Wilcoxon signed-rank tests. For the second purpose, a totalof 404 small metastases were included. The diagnostic sensitivities between 3D T1 gradient echo (GRE) alone and combined results of 3D T1 GRE and 3D T2 FLAIR were compared with McNemar test. Results: The SNR and CR of small brain metastases were significantly higher than those of large brain metastases (p<0.001). In qualitative analysis, the diagnostic sensitivities for small brain metastaseswere significantly higher for 3D T1 GRE plus 3D T2 FLAIR than 3D T1 GRE alone regardless of scan time (p<0.001). Conclusion: Small brain metastases showed higher signal intensity than large brain metastases on the DD Gd enhanced 3D T2 FLAIR images. DD Gd enhanced 3D T2 FLAIR imaging may have a complementaryrole to 3D T1 GRE for evaluating small brain metastases.
참고문헌 (24)
- Vecht CJ, "Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?", Ann Neurol, 33, pp.583~590 (1993)
- Patchell RA, "The management of brain metastases", Cancer Treat Rev, 29, pp.533~540 (2003)
- Chang SD, "Stereoratetactic radiosurgery in patients with multiple brain metastases", Neurosurg Focus, 9, pp.e3~ (2000)
- Yuh WT, "The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis", AJNR Am J Neuroradiol, 16, pp.373~380 (1995)
- Sze G, "Comparison of single- and triple-dose contrast material in the MR screening of brain metastases", AJNR Am J Neuroradiol, 19, pp.821~828 (1998)
- Yuh WT, "Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases", AJNR Am J Neuroradiol, 13, pp.335~345 (1992)
- Vogl TJ, "Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study", Radiologe, 35, pp.508~516 (1995)
- Mathews VP, "Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging", Radiology, 211, pp.257~263 (1999)
- Terae S, "Contrast-enhanced FLAIR imaging in combination with pre- and postcontrast magnetization transfer T1-weighted imaging: usefulness in the evaluation of brain metastases", J Magn Reson Imaging, 25, pp.479~487 (2007)
- Fukuoka H, "Comparison of the added value of contrast-enhanced 3D fluid- attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T", AJNR Am J Neuroradiol, 31, pp.868~873 (2010)
- Tomura N, "Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast- enhanced spin-echo T1-weighted imaging", Acta Radiol, 48, pp.1032~1037 (2007)
- Davis PL, "Interactions of paramagnetic contrast agents and the spin echo pulse sequence", Invest Radiol, 23, pp.381~388 (1988)
- Dietrich O, "Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters", J Magn Reson Imaging, 26, pp.375~385 (2007)
- Heverhagen JT, "Noise measurement and estimation in MR imaging experiments", Radiology, 245, pp.638~639 (2007)
- Sze G, "Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT", AJNR Am J Neuroradiol, 11, pp.785~791 (1990)
- Lorusso G, "The tumor microenvironment and its contribution to tumor evolution toward metastasis", Histochem Cell Biol, 130, pp.1091~1103 (2008)
- Jung S, "Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage", JOURNAL OF NEURO-ONCOLOGY, 76(3), pp.257~263 (2006), KLUWER ACADEMIC PUBL
- Carrier DA, "Metastatic adenocarcinoma to the brain: MR with pathologic correlation", AJNR Am J Neuroradiol, 15, pp.155~159 (1994)
- Hinshaw DB Jr, "Metastatic brain neoplasms", Top Magn Reson Imaging, 1, pp.69~78 (1989)
- Chang EL, "The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases", Neurosurgery, 53, pp.272~280 (2003)
- Ranjan T, "Current management of metastatic brain disease", Neurotherapeutics, 6, pp.598~603 (2009)
- Essig M, "Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging", Radiology, 210, pp.551~557 (1999)
- Ercan N, "Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases", AJNR Am J Neuroradiol, 25, pp.761~765 (2004)
- Thomsen HS, "ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis", Eur Radiol, 17, pp.2692~2696 (2007)